Key Points
- CEO Matthijs Glastra sold 6,500 shares on April 17 at an average price of $130.05 for about $845,325, trimming his stake by 10.27% to 56,761 shares; the transaction was executed under a pre-arranged Rule 10b5-1 plan (he also sold 7,500 shares in both January and February).
- Company results and outlook: Novanta reported $0.91 EPS (beating estimates) and gave FY2026 guidance of $3.50–3.65 EPS, while the stock trades at a ~90.7 P/E with a MarketBeat consensus "Hold" target of $144.
Novanta Inc. (NASDAQ:NOVT - Get Free Report) CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $130.05, for a total transaction of $845,325.00. Following the sale, the chief executive officer owned 56,761 shares in the company, valued at approximately $7,381,768.05. The trade was a 10.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Matthijs Glastra also recently made the following trade(s):
- On Tuesday, February 10th, Matthijs Glastra sold 7,500 shares of Novanta stock. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00.
- On Wednesday, January 21st, Matthijs Glastra sold 7,500 shares of Novanta stock. The shares were sold at an average price of $140.00, for a total transaction of $1,050,000.00.
Novanta Trading Up 0.1%
NASDAQ:NOVT opened at $132.40 on Wednesday. The company's 50 day moving average price is $128.14 and its 200-day moving average price is $123.07. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $149.95. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. The stock has a market cap of $4.72 billion, a price-to-earnings ratio of 90.68 and a beta of 1.64.
Novanta (NASDAQ:NOVT - Get Free Report) last posted its quarterly earnings results on Monday, February 23rd. The technology company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The firm had revenue of $258.35 million for the quarter, compared to analysts' expectations of $260.72 million. During the same quarter in the prior year, the company posted $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, equities research analysts forecast that Novanta Inc. will post 3.54 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in NOVT. Pilgrim Partners Asia Pte Ltd bought a new position in Novanta in the third quarter worth approximately $36,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in Novanta in the third quarter worth approximately $40,000. Danske Bank A S bought a new position in Novanta in the third quarter worth approximately $40,000. Allworth Financial LP raised its position in Novanta by 978.4% in the fourth quarter. Allworth Financial LP now owns 399 shares of the technology company's stock worth $47,000 after acquiring an additional 362 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in Novanta by 120.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company's stock worth $51,000 after acquiring an additional 233 shares during the period. 98.35% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on NOVT shares. Robert W. Baird upgraded shares of Novanta from a "neutral" rating to an "outperform" rating and cut their price target for the company from $150.00 to $144.00 in a report on Monday, March 30th. Wall Street Zen cut shares of Novanta from a "buy" rating to a "hold" rating in a report on Saturday. Weiss Ratings restated a "hold (c-)" rating on shares of Novanta in a research report on Friday. Finally, Zacks Research upgraded shares of Novanta from a "strong sell" rating to a "hold" rating in a research report on Friday, January 16th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $144.00.
Get Our Latest Stock Report on Novanta
About Novanta
(
Get Free Report)
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
